| Lonza Group AG. (1/19/21). "Press Release: NextPharma Set to Acquire Two Lonza Sites Specialized in Lipid Oral Dosage Forms". Basel & London. |
2021-01-19 |
| Creoptix AG. (1/12/21). "Press Release: Domainex Invests in the Creoptix WAVEdelta to Strengthen Its Fragment-based Drug Discovery Platform. Strong Partnership Ahead". Wädenswil & Saffron Walden. |
2021-01-12 |
| Addex Therapeutics S.A.. (1/11/21). "Press Release: Addex Successfully Completes $11.5 Million Capital Increase Including Full Exercise of Underwriter’s Option to Purchase Additional Securities". Geneva. |
2021-01-11 |
| Novartis AG. (1/11/21). "Press Release: Novartis Expands Oncology Pipeline with In-licensing of Tislelizumab from BeiGene". Basel. |
2021-01-11 |
| Qiagen N.V.. (1/8/21). "Press Release: Qiagen Announces Appointment of New Supervisory Board Member". Venlo. |
2021-01-08 |
| Ribometrix, Inc.. (1/6/21). "Press Release: Ribometrix Announces Collaboration with Genentech to Discover and Develop RNA-Targeted Small Molecule Therapeutics". Durham, NC. |
2021-01-06 |
| Arvelle Therapeutics GmbH. (1/4/21). "Press Release: Angelini Pharma Acquires Arvelle Therapeutics to Create a Leading European Innovator in Central Nervous System (CNS) and Mental Health Disorder Treatments". Rome. |
2021-01-04 |
| BioNTech SE. (12/19/20). "Press Release: Pfizer and BioNTech Receive Conditional Marketing Authorization by Swissmedic for COVID-19 Vaccine". Zürich & Mainz. |
2020-12-19 |
| SGS S.A.. (12/18/20). "Press Release: SGS Ends Share Buyback Program". |
2020-12-18 |
| Novartis AG. (12/17/20). "Press Release: Novartis Builds on Commitment to Addressing Need in Neuropsychiatric Disorders with Cadent Therapeutics Acquisition". Basel. |
2020-12-17 |
| Cadent Therapeutics. (12/17/20). "Press Release: Cadent Therapeutics Enters Agreement to Be Acquired by Novartis". Cambridge, MA. |
2020-12-17 |
| ECBF Management GmbH. (12/15/20). "Press Release: The European Circular Bioeconomy Fund Has Raised €175 Million to Foster Sustainable Innovations". Luxembourg. |
2020-12-15 |
| ECBF Management GmbH. (12/15/20). "Press Release: The European Circular Bioeconomy Fund Welcomes Nestlé as an Investor to Accelerate Sustainable Innovation in Europe". Luxembourg. |
2020-12-15 |
| ADC Therapeutics S.A.. (12/14/20). "Press Release: ADC Therapeutics and Overland Pharmaceuticals Announce Formation of Overland ADCT BioPharma to Develop and Commercialize Lonca and other ADCs for Hematologic and Solid Tumor Indications in Greater China |
2020-12-14 |
| Nouscom AG. (12/11/20). "Press Release: Nouscom Appoints Göran Ando MD as Chairman and Richard Davis PhD as Chief Business Officer". Basel. |
2020-12-11 |
| Boehringer Ingelheim. (12/10/20). "Press Release: Boehringer Ingelheim to Acquire NBE-Therapeutics for EUR 1.18 Billion, Significantly Enhancing Its Cancer Pipeline Portfolio with Novel Antibody-Drug Conjugates". Ingelheim & Basel. |
2020-12-10 |
| RetinAI Medical AG. (12/8/20). "Press Release: RetinAI Announces Collaboration with Novartis to Provide Artificial Intelligence Solutions in Ophthalmology". Bern. |
2020-12-08 |
| Creoptix AG. (11/25/20). "Press Release: Creoptix and oneservice Partner for WAVEsystem After-sales Support". Wädenswil (Zurich). |
2020-11-25 |
| Voluntis S.A.. (11/23/20). "Press Release: Voluntis Successfully Completes a Capital Increase of €5.9 Million and Finalizes the Financing of Its Strategic Roadmap [Not for US, CA, AU or JP] Japan.". Cambridge, MA & Paris. |
2020-11-23 |
| Novartis AG. (11/19/20). "Press Release: Novartis Secures Exclusive Rights for Potential Acute Respiratory Distress Syndrome Cell Therapy". Basel. |
2020-11-19 |
| Lino Biotech AG. (11/17/20). "Press Release: Lino Biotech Closes Seed Financing Round and Showcases a Novel Label-free Biosensor Platform for Innovate Modern Drug Screening". Zurich. |
2020-11-17 |
| Lead Pharma Holding B.V.. (11/16/20). "Press Release: Lead Pharma Enters into a Research Collaboration and License Agreement with Roche to Develop Oral Small Molecules for Immune Mediated Diseases". |
2020-11-16 |
| Synendos Therapeutics AG. (11/12/20). "Press Release: Synendos Therapeutics Raises CHF 20 Million in Series A Financing". Basel. |
2020-11-12 |
| Vifor Pharma AG. (11/09/20). "Press Release: Vifor Pharma and Angion Sign License Agreement for ANG-3777 in Nephrology Indications". St. Gallen & Uniondale, NY. |
2020-11-09 |
| Merck KGaA. (11/9/20). "Press Release: Merck Announces Out-licensing Agreement for Investigational Atacicept with Vera Therapeutics [Not intended for UK and US based media]". Darmstadt. |
2020-11-09 |
| Memo Therapeutics AG. (11/5/20). "Press Release: Memo Therapeutics AG Raises CHF 14 Million in a Series B Financing Round". Schlieren. |
2020-11-05 |
| Novartis AG. (10/29/20). "Press Release: Novartis Acquires Vedere Bio, Adding Novel Optogenetic Gene Therapy Technology for Treating Blindness". Basel. |
2020-10-29 |
| CRISPR Therapeutics AG. (10/28/20). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2020 Financial Results". Zug & Cambridge, MA. |
2020-10-28 |
| Bayer AG. (10/27/20). "Press Release: Bayer Appoints Dr. Christian Rommel as New Head of Pharmaceuticals Research and Development". Berlin. |
2020-10-27 |
| NBE Therapeutics AG. (10/26/20). "Press Release: NBE-Therapeutics Commences First Clinical Study of Anti-ROR1 Antibody-Drug Conjugate for Patients with Solid Tumors". Basel. |
2020-10-26 |
| Araris Biotech AG. (10/22/20). "Press Release: Araris Biotech Completes CHF 15.2 Million Seed Financing Round". Zürich. |
2020-10-22 |
| Atea Pharmaceuticals, Inc.. (10/22/20). "Press Release: Atea Pharmaceuticals Announces Strategic Collaboration with Roche to Develop and Distribute AT-527 for Patients with COVID-19". Boston, MA. |
2020-10-22 |
| Selexis S.A.. (10/20/20). "Press Release: JSR Life Sciences Expands Its European Gene-to-GMP Biologics Manufacturing Facilities for Selexis and KBI Biopharma in Geneva, Switzerland". Sunnyvale, CA. |
2020-10-20 |
| Vifor Pharma AG. (10/20/20). "Press Release: Vifor Pharma and Cara Therapeutics Sign US License Agreement for i.v. Korsuva to Treat Dialysis Patients with Pruritus". St. Gallen & Stamford, CT. |
2020-10-20 |
| Centogene N.V.. (10/20/20). "Press Release: Centogene Announces Leadership Transition". Cambridge, MA & Rostock. |
2020-10-20 |
| Selexis S.A.. (10/16/20). "Press Release: Selexis Names Biopharmaceutical Executive Dirk Lange as New Chief Executive Officer". Geneva. |
2020-10-16 |
| VectivBio AG. (10/15/20). "Press Release: VectivBio Closes $110 Million Crossover Financing to Advance Transformational Medicines for Rare Diseases". Basel. |
2020-10-15 |
| Polyphor Ltd.. (10/14/20). "Press Release: Polyphor Receives CARB-X Award of up to USD 18.44 Million to Support Development of New Antibiotic Program". Allschwil. |
2020-10-14 |
| Chord Therapeutics S.A.. (10/13/20). "Press Release: Chord Therapeutics Launches with USD 16 Million Series A Financing from Omega Funds". |
2020-10-13 |
| Rappta Therapeutics Oy. (10/13/20). "Press Release: Rappta Therapeutics Raises Series A Financing for the Development of Phosphatase 2A Drugs". Helsinki. |
2020-10-13 |
| Oxurion N.V.. (10/13/20). "Press Release: Oxurion NV Appoints Tom Graney, CFA as Chief Financial Officer". Leuven & Boston, MA. |
2020-10-13 |
| Precigen, Inc.. (10/9/20). "Press Release: Precigen Announces Merck KGaA, Darmstadt, Germany Increases Ownership Position Through Exercise of Convertible Note". Germantown, MD. |
2020-10-09 |
| Relief Therapeutics Holding AG. (10/8/20). "Press Release: Relief Therapeutics Appoints Industry Veteran, Jack Weinstein, as Chief Financial Officer and Treasurer". Geneva. |
2020-10-08 |
| Merck KGaA. (10/6/20). "Press Release: Merck Announces Out-Licensing Agreement for Phase II-ready Anti-ADAMTS5 Nanobody for Osteoarthritis [Not intended for UK and US based media]". Darmstadt. |
2020-10-06 |
| Santhera Pharmaceuticals Holding AG. (10/6/20). "Press Release: Santhera to Discontinue Phase 3 SIDEROS Study and Development of Puldysa in Duchenne Muscular Dystrophy (DMD) and Focus on Vamorolone". Pratteln. |
2020-10-06 |
| Sophia Genetics S.A.. (10/1/20). "Press Release: Sophia Genetics Raises $110 Million in Oversubscribed New Funding Round". Lausanne & Boston, MA. |
2020-10-01 |
| Numab Therapeutics AG. (9/30/20). "Press Release: Numab Therapeutics Appoints Daniel Vasella as New Chairman of the Board". Wädenswil (Zurich). |
2020-09-30 |
| BaseLaunch (BaselArea.swiss). (9/28/20). "Press Release: BaseLaunch Announces that Johnson & Johnson Innovation Has Renewed Its Commitment Becoming Latest Strategic Partner in the Second Phase". Basel. |
2020-09-28 |
| BB Pureos Bioventures. (9/23/20). "Press Release: Pureos Bioventures Closes First Fund with USD 170 Million". St. Peter Port, Guernsey & Küsnacht. |
2020-09-23 |
| Inflazome Ltd.. (9/21/20). "Press Release: Inflazome Announces Acquisition by Roche". Dublin & Cambridge. |
2020-09-21 |
| NovaGo Therapeutics AG. (9/21/20). "Press Release: NovaGo Therapeutics Appoints Ian Metcalfe as CEO". Schlieren. |
2020-09-21 |
| Polyneuron Pharmaceuticals AG. (9/16/20). "Press Release: Polyneuron Extends Series A to CHF 36.5 Million with Additional CHF 14 Million". Basel. |
2020-09-16 |
| Moderna, Inc.. (9/16/20). "Press Release: Moderna Announces First Commercial Organization Outside North America in Switzerland". Cambridge, MA. |
2020-09-16 |
| Dinaqor AG. (9/16/20). "Press Release: Dinaqor AG Appoints Eduard Ayuso as Chief Technology Officer". Pfäffikon. |
2020-09-16 |
| NBE Therapeutics AG. (9/8/20). "Press Release: Exelixis and NBE-Therapeutics Enter into Exclusive Collaboration and License Option Agreement to Discover and Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer". Alameda, CA & Basel. |
2020-09-08 |
| Lonza Group Ltd.. (9/8/20). "Press Release: Sheba Medical Center Treats First Patient with CAR-T Cell Immunotherapy Manufactured Using the Lonza Cell Immunotherapy Manufactured Using the Lonza Cocoon Platform". Basel & Tel Aviv. |
2020-09-08 |
| Debiopharm International SA. (9/7/20). "Press Release: Belgian Scale-up Oncomfort Raises €10 million in Series A Funding Co-led by Debiopharm and Crédit Mutuel Innovation". Brussels, Lausanne & Paris. |
2020-09-07 |
| EuropaBio. (9/3/20). "Press Release: Novartis’s Andrew Topen Appointed as New Chairman of EuropaBio". |
2020-09-03 |
| Oculis S.A.. (9/1/20). "Press Release: Oculis Establishes Presence in U.S. and Appoints Sylvia Cheung as Chief Financial Officer". Lausanne. |
2020-09-01 |
| BioVersys AG. (9/1/20). "Press Release: BioVersys Announces CHF 19 Million Financing to Advance Novel AMR Candidates into Clinical Development". Basel. |
2020-09-01 |
| Semalytix GmbH. (8/31/20). "Press Release: Semalytix Closes Series A Investment Totaling €4.3m". |
2020-08-31 |
| Aimmune Therapeutics, Inc.. (8/31/20). "Press Release: Aimmune Therapeutics Enters Definitive Agreement with Sociétés des Produits Nestlé S.A., Part of Nestlé Health Science". Brisbane, CA. |
2020-08-31 |
| Addex Therapeutics S.A.. (8/27/20). "Press Release: Addex and the SIB Swiss Institute of Bioinformatics Receive Innosuisse Grant to Repurpose Potent Dopamine Antagonist Using Computational Modelling". Geneva. |
2020-08-27 |
| NBE Therapeutics AG. (8/10/20). "Press Release: NBE-Therapeutics Appoints Erich Schlick as Chairman of the Board of Directors". Basel. |
2020-08-10 |
| T-Knife GmbH. (8/6/20). "Press Release: T-Knife Completes € 66 Million Series A Financing to Develop Next-Generation T-Cell Therapies". Berlin. |
2020-08-06 |
| AC Immune S.A.. (8/5/20). "Press Release: AC Immune Reports Q2 2020 Financial Results and Provides Business Update". Lausanne. |
2020-08-05 |
| Versant Ventures. (8/5/20). "Press Release: Versant Ventures Launches Matterhorn Biosciences". Basel. |
2020-08-05 |
| GentiBio, Inc.. (8/5/20). "Press Release: GentiBio Launches with $20M Seed Funding from OrbiMed, Novartis Venture Fund and RA Capital Management, L.P. to Develop Engineered Regulatory T cells to Deliver Immune Tolerizing Therapies for Autoimmune and Infl |
2020-08-05 |
| NBE Therapeutics AG. (8/3/20). "Press Release: NBE-Therapeutics Appoints Bertrand Damour as Chief Executive Officer". Basel. |
2020-08-03 |
| PharmaLex GmbH. (8/1/20). "Press Release: PharmaLex Strengthens Its Commercial Organization". Frankfurt. |
2020-08-01 |
| BaselArea.swiss. (7/31/20). "Press Release: Yokogawa Establishes Innovation Center in Allschwil". |
2020-07-31 |
| Alentis Therapeutics AG. (7/29/20). "Press Release: Alentis Therapeutics Names Roberto Iacone CEO". Basel. |
2020-07-29 |
| Polyphor Ltd.. (7/28/20). "Press Release: Polyphor Strengthens Financial Flexibility with CHF 19.3 million Equity-linked Financing". Allschwil. |
2020-07-28 |
| T3 Pharmaceuticals AG. (7/22/20). "Press Release: T3 Pharma Raises 25M CHF to Advance Bacterial Cancer Therapy through Clinic". Basel. |
2020-07-22 |
| Gain Therapeutics, Inc.. (7/21/20). "Press Release: Gain Therapeutics, Inc. Announces Close of $10 Million Series B Financing". Bethesda, MD. |
2020-07-21 |
| Tubulis GmbH. (7/21/20). "Press Release: Tubulis Raises €10.7 M Series A to Advance Development of a New Generation of Antibody-Drug Conjugates". Munich. |
2020-07-21 |
| Zur Rose Group AG. (7/16/20). "Press Release: Zur Rose Group Acquires TeleClinic, Germany's Leading Telemedicine Provider". |
2020-07-16 |
| Merck KGaA. (7/15/20). "Press Release: Merck Invests € 18 Million in New Life Science Laboratory in Switzerland". Darmstadt. |
2020-07-15 |
| Versameb AG. (7/15/20). "Press Release: Versameb Raises CHF 6 Million and Strengthens Team to Advance Its VERSagile Technology Platform towards Clinical Trials". Basel. |
2020-07-15 |
| Roche. (7/14/20). "Press Release: Roche Collaborates with Blueprint Medicines to Bring a New Treatment to People with RET-altered Cancers". Basel. |
2020-07-14 |
| iOnctura S.A.. (7/14/20). "Press Release: iOnctura Extends Series A to EUR 20.1m". Geneva. |
2020-07-14 |
| Anergis S.A.. (7/9/20). "Press Release: Anergis and Virometix Announce Research Collaboration to Use Synthetic Virus-Like Particles for Ultra-Fast Allergy Immunotherapy". Epalinges. |
2020-07-09 |
| Kaiku Health. (7/8/20). "Press Release: Kaiku Health Expands Collaboration with Roche in Digital Patient Monitoring and Management". |
2020-07-08 |
| Numab Therapeutics AG. (7/7/20). "Press Release: Numab Therapeutics and Boehringer Ingelheim Enter into Collaboration to Develop Multi-specific Antibody Therapeutics for Cancer and Retinal Diseases". Wädenswil & Ingelheim. |
2020-07-07 |
| Debiopharm International SA. (7/7/20). "Press Release: Nucleai Secured $6.5m Series-A Initial Closing Led by Debiopharm to Advance Ai-Powered Precision Oncology Platform". Tel Aviv & Lausanne. |
2020-07-07 |
| Idorsia Ltd.. (7/6/20). "Press Release: Idorsia Announces Positive Results in the Second Phase 3 Study of Daridorexant". Allschwil. |
2020-07-06 |
| Resistell AG. (7/3/20). "Press Release: Resistell AG Receives €2.5m EIC Accelerator Grant and Equity Financing Offer from EIC". |
2020-07-03 |
| CRISPR Therapeutics AG. (6/30/20). "Press Release: CRISPR Therapeutics Announces Pricing of Public Offering of Common Shares". Zug & Cambridge, MA. |
2020-06-30 |
| Cutiss AG. (6/29/20). "Press Release: Series B Financing Oversubscribed. Cutiss Closes Series B Funding – Target of CHF 20 Million Oversubscribed". Zurich. |
2020-06-29 |
| CRISPR Therapeutics AG. (6/29/20). "Press Release: CRISPR Therapeutics Announces Proposed Offering of Common Shares". Zug & Cambridge, MA. |
2020-06-29 |
| Biognosys AG. (6/17/20). "Press Release: Biognosys Announces Appointment of Dr. Patrick Vink as Chairman". Schlieren. |
2020-06-17 |
| Lonza Group Ltd.. (6/5/20). "Press Release: Lonza Appoints New Chief Executive Officer". Basel. |
2020-06-05 |
| Delta 4 GmbH. (6/2/20). "Press Release: Delta 4 Announces Results Achieved with Drug Discovery Platform". Vienna. |
2020-06-02 |
| Monte Rosa Therapeutics. (5/26/20). "Press Release: Monte Rosa Therapeutics Discloses $32.5 Million Financing. Launched from Versant’s Ridgeline Discovery Engine". Boston, MA & Basel. |
2020-05-26 |
| Proteomedix AG. (5/26/20). "Press Release: Proteomedix Appoints Dr Maurizio Ballerini, MD as VP Market Development EMEA and Dr Helene Peyro Saint-Paul, MD as Medical Advisor". Zürich-Schlieren. |
2020-05-26 |
| Idorsia Ltd.. (5/20/20). "Press Release: Idorsia Successfully Completes the Offering of New Shares thereby Securing Funding for the Company’s Growth Plan". Allschwil. |
2020-05-20 |
| Idorsia Ltd.. (5/19/20). "Press Release: Idorsia Launches an Offering of New Shares to Fund the Company’s Growth plan". Allschwil. |
2020-05-19 |
| Proteomedix AG. (5/19/20). "Press Release: Analytical Performance of Proclarix Verified". Zürich-Schlieren. |
2020-05-19 |
| BaseLaunch (BaselArea.swiss). (5/15/20). "Press Release: Roche Becomes Founding Partner of BaseLaunch Phase II". Basel. |
2020-05-15 |
| Roche. (5/14/20). "Press Release: Roche to Present First Clinical Data on Novel Anti-TIGIT Cancer Immunotherapy Tiragolumab at ASCO". Basel. |
2020-05-14 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
Date![Picture [iito] Männer Ballett 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-maenner-ballett.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
